Friday, 5 June 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 5 June 2026
Ascott 1
Ascott 1
Latest News
Who's flexing the hottest pipeline?

There's a new leader on the much-coveted 2026 Pharmaceutical Invention Index which ranks companies not just on their current breakthroughs but on what they are working to deliver next.

A PBAC funding model that works?
New blueprint proposes removal of lowest cost comparator to boost both innovative medicine launches and biosim uptake
TODAY
Lilly showcases Alzheimer's data
Evidence and real-world data presented at Aussie forum that should build confidence in earlier, more accurate diagnoses
TODAY
Medscape
Medscape
Most Popular
Pharma winners and losers in Q1
Industry saw good sales growth in the first quarter of this year, with some soaring to new heights while others went backwards
4 June
Key leadership changes hit industry
Pharma bosses seem to be on the move again with significant hires, promotions and departures across companies
4 June
Industry pain point finally solved?
Well-known pharma leader has developed an AI platform, specifically for Aussie pharma and it could transform industry
3 June
'One-in-a-million' exec departs
After 24 years and an impressive track record, this senior leader is leaving, with a former boss branding him a rare talent
3 June
HPG
HPG
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (22)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (4)

Executive Roles (9)

Other (11)

More News
Great workplace? GM says no surprise
Official certification from GPTW came as no surprise to this boss who knows first-hand about the camaraderie, culture and value of his team
4 June
Companies snag inclusion gongs
Five pharmas have been recognised at the Australian LGBTQ+ Inclusion Awards, with one a first-time winner
4 June
Three big drugs start funding run
Pharma applications to be considered by an MSAC subcommittee, including one which was previously withdrawn
4 June
Drug titan almost doubles wealth
Founder of Australia's generics giant has doubled his wealth in a year after a push into innovative medicine and consumer goods
3 June
Aust added to drug licensing deal
Expanded licensing agreement set to see therapy delivered by unique 'Patchless Patch' technology, reach Australia
3 June
Who's signed this Sydney biotech?
Company announces it has licensed its product to a multi-billion dollar international pharma, but won't say which one just yet
3 June
Price cuts hit $168M in PBS brands
After less than a year on the ARTG, these generics have scored a PBS listing - slashing the price of three brands
2 June
GSK shuffles Govt Affairs team
Leader promoted into an international position - see which colleague has stepped into the Australian Govt Affairs & Policy role
2 June
Round 2: Blockbuster fight reignites
A pharma is dashing to the courts as drugs pulling in $164 million annually face a statutory price cut despite not facing generic competition
2 June
Ex-MA senior exec lands CEO role
Appointed inaugural CEO and described as 'a real get' for this organisation representing a high-profile sector of industry
2 June
Pfizer rolls dice on 12 cancer drugs
Doubling down in oncology with a deal worth up to US$10.5 billion with a Chinese biotech to develop a dozen new cancer therapies
2 June
June PBS listings unpacked
Changes to the PBS listings of a BTK and a bispecific T-cell engagers has been made alongside the introduction of an additional adrenaline autoinjector
1 June New to the PBS
TGA tick highlights genetic testing
Approval for a targeted drug shines a light on the need to increase community awareness of genetic testing
1 June
More Aussie pharma jobs go
This Big Pharma says its future depends on becoming even more resilient and agile in the face of mounting industry pressures
1 June
PiF advertise
PiF advertise
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe